GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $67,000 | 0.0% | 1,529 | 0.0% | 0.03% | +21.7% |
| Q1 2022 | $67,000 | +1.5% | 1,529 | +1.8% | 0.02% | 0.0% |
| Q4 2021 | $66,000 | +10.0% | 1,502 | -4.3% | 0.02% | -4.2% |
| Q3 2021 | $60,000 | -4.8% | 1,570 | 0.0% | 0.02% | -17.2% |
| Q2 2021 | $63,000 | +12.5% | 1,570 | 0.0% | 0.03% | +7.4% |
| Q1 2021 | $56,000 | +60.0% | 1,570 | +63.4% | 0.03% | +22.7% |
| Q4 2020 | $35,000 | -2.8% | 961 | 0.0% | 0.02% | -12.0% |
| Q3 2020 | $36,000 | -59.1% | 961 | -55.6% | 0.02% | -61.5% |
| Q2 2020 | $88,000 | +175.0% | 2,166 | +157.9% | 0.06% | +140.7% |
| Q1 2020 | $32,000 | -17.9% | 840 | 0.0% | 0.03% | 0.0% |
| Q4 2019 | $39,000 | +8.3% | 840 | 0.0% | 0.03% | +28.6% |
| Q3 2019 | $36,000 | -37.9% | 840 | -41.7% | 0.02% | -36.4% |
| Q2 2019 | $58,000 | -3.3% | 1,440 | 0.0% | 0.03% | -5.7% |
| Q1 2019 | $60,000 | +17.6% | 1,440 | +7.5% | 0.04% | +12.9% |
| Q4 2018 | $51,000 | -7.3% | 1,340 | +3.5% | 0.03% | -20.5% |
| Q1 2017 | $55,000 | – | 1,295 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |